{"url_path":"/sec/silo/8-k/2026-06-03/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 Amendments","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1514183/0001213900-26-064804-index.html","accession_number":"0001213900-26-064804","cik":"0001514183","ticker":"SILO","issuer_name":"Silo Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1514183/0001213900-26-064804-index.html","primary_entity_key":"0001514183","primary_entity_name":"Silo Pharma, Inc."},"word_count":342,"has_tables":true,"body_markdown":"** **\n\n**Item 5.03 Amendments\nto Articles of Incorporation or Bylaws; Change in Fiscal Year.**\n\n** **\n\nOn June 1, 2026, Silo\nPharma, Inc. (the “Company”) filed a Certificate of Change (the “Certificate of Change”) with the Secretary of\nState of the State of Nevada to effectuate a 1-for-15 reverse stock split (the “Reverse Stock Split”) of the Company’s\nissued and outstanding and authorized shares of common stock, par value $0.0001 per share (“Common Stock”). The Reverse Stock\nSplit became effective at 4:01 p.m., Eastern Time, on Tuesday, June 2, 2026, and the Company’s Common Stock began trading on a split-adjusted\nbasis when The Nasdaq Stock Market (“Nasdaq”) opened on June 3, 2026.\n\n \n\nWhen the Reverse Stock\nSplit became effective, every 15 shares of Common Stock issued and outstanding were automatically reclassified and combined into one share\nof Common Stock, without any change in the par value per share, and a proportionate reduction was made to the Company’s authorized\nshares of Common Stock such that the Company now has 6,666,667 shares of authorized Common Stock. In addition, a proportionate adjustment\nhas been made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options and\nwarrants to purchase shares of Common Stock and the number of shares reserved for issuance pursuant to the Company’s equity incentive\ncompensation plans. No fractional shares of Common Stock were issued in connection with the Reverse Stock Split. Stockholders who otherwise\nwould have been entitled to receive fractional shares of Common Stock had their holdings rounded up to the next whole share.\n\n \n\nThe Company’s Common\nStock will continue to trade on The Nasdaq Capital Market under the existing symbol “SILO”, but the security has been assigned\na new CUSIP number (82711P 300).\n\n \n\nThe foregoing description\nof the Certificate of Change does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate\nof Change which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference."}